What are the published peer-reviewed studies supporting the Yenos/OncuraKit platform?

The Yenos platform is supported by four peer-reviewed publications: (1) Kanavarioti A. (2020). 'Ready-to-use nanopore platform for the detection of any DNA/RNA oligo.' Scientific Reports, 10, 19790. doi:10.1038/s41598-020-76667-1 — Proof of concept for the nanopore detection approach. (2) Kanavarioti A et al. (2022). 'Femtomolar-level PCR-free quantification of microRNA cancer biomarkers in serum.' bioRxiv preprint. doi:10.1101/2022.12.30.522268 — Demonstration of amplification-free miRNA quantification at clinical concentrations. (3) Kanavarioti A, Rehman MH, Qureshi S, Rafiq A, Sultan M. (2024). 'High Sensitivity and Specificity Platform to Validate MicroRNA Biomarkers in Cancer and Human Diseases.' Non-Coding RNA, 10(4):42. doi:10.3390/ncrna10040042 — Cancer vs. healthy validation confirming 1.83× HL overexpression. (4) Rafiq A, Kanavarioti A. (2025). 'The Potential and Limitations of the MinION/Yenos Platform for miRNA-Enabled Early Cancer Detection.' Int. J. Mol. Sci., 26(8), 3822. doi:10.3390/ijms26083822 — Comprehensive study reporting per-marker accuracy and zero data overlap.